Advanced Biotherapeutics Consulting (ABC) (FR)

Advanced Biotherapeutics Consulting (ABC) is a translational accelerator that de-risks gene therapy programs with therapeutic potential. The expertise of ABC covers all steps of gene-based drug development for translating an early stage preclinical project to a clinical trial and beyond, particularly in the field of genetic diseases. ABC areas of expertise are preclinical proof-of-concept, regulatory toxicology studies, viral vector manufacturing and quality control, and regulatory strategies to meet EMA requirements. It relies on the Nantes Gene Therapy Institute headed by Philippe Moullier, MD, PhD, an internationally recognized expert. *

	Start	2016-01-13 existent
	Industry	adeno-associated viral vector (AAV vector)

	Region	France_oo
	Country	France
	City	n. a.
		Address record changed: 2016-01-14

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]